Showing results (61-70 of 5,388) with videos related to
Sort By:
Pageof 539
Mediators of Inflammation|April 22, 2017
Innate Immunity of Adipose Tissue in Rodent Models of Local and Systemic Staphylococcus aureus InfectionAndreas Schmid, Thomas Karrasch, Miriam Thomalla, et al.Mediators of Inflammation|February 9, 2012
A comparative in vitro study of the effects of separate and combined products of Citrus e fructibus and Cydonia e fructibus on immunological parameters of seasonal allergic rhinitisE W Baars, M C Jong, I Boers, et al.Mediators of Inflammation|February 9, 2012
Pegylated arginine deiminase downregulates colitis in murine modelsHelieh S Oz, Jian Zhong, Willem J S de VilliersMediators of Inflammation|September 24, 2011
Angiogenesis-related cytokines, RANKL, and osteoprotegerin in multiple myeloma patients in relation to clinical features and response to treatmentK Sfiridaki, C A Pappa, G Tsirakis, et al.Mediators of Inflammation|April 13, 2012
Effects of trauma-hemorrhage and IL-6 deficiency on splenic immune function in a murine trauma modelP Mommsen, T Barkhausen, C Zeckey, et al.Mediators of Inflammation|April 13, 2012
Involvement of the ubiquitin-proteasome system in the formation of experimental postsurgical peritoneal adhesionsClara Di Filippo, Pasquale Petronella, Fulvio Freda, et al.Mediators of Inflammation|April 5, 2012
Microalbuminuria and sRAGE in high-risk hypertensive patients treated with nifedipine/telmisartan combination treatment: a substudy of TALENTColomba Falcone, Maria Paola Buzzi, Sara Bozzini, et al.Mediators of Inflammation|December 17, 2011
Inflammatory mediators release in urine from mice injected with Crotalus durissus terrificus venomA Hernández Cruz, L Barbosa Navarro, R Z Mendonça, et al.Mediators of Inflammation|July 26, 2011
Novel interventional approaches for ALI/ARDS: cell-based gene therapyYing-Gang Zhu, Jie-Ming Qu, Jing Zhang, et al.Mediators of Inflammation|July 21, 2011
Evaluation of plaque stability of advanced atherosclerotic lesions in apo E-deficient mice after treatment with the oral factor Xa inhibitor rivaroxabanQianxing Zhou, Florian Bea, Michael Preusch, et al.Pageof 539